L
Lykon
An innovative health care company that provides digital health coaching based on Biomarker analysis
About Lykon
Lykon operates in the personalized health and wellness market, offering at-home blood and DNA tests to help individuals optimize their diet and nutrient intake. The company serves health-conscious consumers looking to tailor their dietary and lifestyle choices based on their unique genetic and metabolic profiles. Lykon's business model revolves around selling test kits directly to consumers through their website, as well as offering subscription-based services for ongoing health monitoring and personalized recommendations. Revenue is generated from the sale of these test kits and subscription services. The company leverages advanced biotechnology to provide actionable insights, making it easier for clients to achieve their health and wellness goals.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2015
- Headquarters
- Berlin, Germany
- Employees
- 29
- Open positions
- None listed
- Dealroom signal
- 65.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Weight Management, Nutrition, Microbiome, Metabolism, Hard Tech, Woman Founder, Longevity
- Business model
- Marketplace & ecommerce
- Client focus
- b2b, b2c
- Investment activity
- 1 company, latest Jun 2021
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jun 2024 | $0 | — | Lifesum | ↗ |
| EARLY VC✓Equity / VC | Aug 2023 | $2.8M | $55M | ZINTINUS | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Lykon is 39K monthly website visits, up 85.7% over the last three months. Lykon's team declined 19.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Ippen Media
MA Ventures
Series A2 investors entered at this stage
ZINTINUS
BTG Bridge To Growth
Series B and later1 investor entered at this stage
Redstone
Other known investors6 additional known investors
Lifesum
8eyes
AC & Friends
Caesar Business Angels
Ey Ventures
Reimann Investors
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lykon on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lykon’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.